transdermal ozone associated with lower systolic blood pressure in chronic kidney stress model
Ozone-treated rats with chronic renal failure exhibited significantly lower systolic arterial pressure (157 ± 9 mmHg) compared to positive control (165 ± 13) and oxygen control (167 ± 15) groups, though still higher than negative controls (111 ± 13).
What this means for you
In this animal study, ozone exposure was linked to meaningfully lower systolic blood pressure compared to untreated and oxygen-only groups under conditions of chronic kidney stress. Healthy blood pressure is one of the most important markers of cardiovascular and long-term wellness — so findings that point to pressure-lowering responses are worth understanding, even as early-stage research.
The published research
Ozone: A Possible Agent that Delays the Chronic Renal
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.